ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

FDA-Approved Agents for the Treatment of MCL

Owen O'Connor, MD, PhD
Published Online:5:22 PM, Wed November 15, 2017

Owen O'Connor, MD, PhD, professor of medicine and Experimental Therapeutics, director of the Center for Lymphoid Malignancies, Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, discusses the agents approved by the FDA for the treatment of mantle cell lymphoma (MCL), including acalabrutinib (Calquence) and bortezomib (Velcade).
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.